Get startedLog in
    Picture of Shanghai Haohai Biological Technology Co logo

    6826 — Shanghai Haohai Biological Technology Co Income Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapContrarian
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Shanghai Haohai Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    CAS
    CAS
    CAS
    CAS
    CAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,7672,1302,6542,6982,473
    Cost of Revenue
    Gross Profit1,2751,4611,8641,8531,712
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,3841,8962,1472,2302,253
    Operating Profit383234507467220
    Gain / Loss on Sale of Assets
    Other Net Non Operating Costs
    Net Income Before Taxes383236508466239
    Provision for Income Taxes
    Net Income After Taxes347190412376208
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income352180416420251
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income352180416420251
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS1.430.8981.741.91.74
    Dividends per Share